PubMed registered articles Jorrit M. Enserink

Publications by Jorrit M. Enserink

70 publications found

Publications 2024

  1. Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
    CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
    Cell Rep Med, 5 (6), 101572
    DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
  2. Corrales J, Ramos-Alonso L, González-Sabín J, Ríos-Lombardía N, Trevijano-Contador N, Engen Berg H, Sved Skottvoll F, Moris F, Zaragoza O, Chymkowitch P, Garcia I, Enserink JM (2024)
    Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole
    Microbiol Spectr, 12 (2), e0259423
    DOI 10.1128/spectrum.02594-23, PubMed 38230926
  3. Fuentes-Martín R, Ayuda-Durán P, Hanes R, Gallego-Yerga L, Wolterinck L, Enserink JM, Álvarez R, Peláez R (2024)
    Promising anti-proliferative indolic benzenesulfonamides alter mechanisms with sulfonamide nitrogen substituents
    Eur J Med Chem, 275, 116617
    DOI 10.1016/j.ejmech.2024.116617, PubMed 38959729
  4. Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K (2024)
    Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data
    PLoS Comput Biol, 20 (3), e1011888
    DOI 10.1371/journal.pcbi.1011888, PubMed 38446830

Publications 2023

  1. Al Outa A, Hicks S, Thambawita V, Andresen S, Enserink JM, Halvorsen P, Riegler MA, Knævelsrud H (2023)
    CELLULAR, A Cell Autophagy Imaging Dataset
    Sci Data, 10 (1), 806
    DOI 10.1038/s41597-023-02687-x, PubMed 37973836
  2. Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM (2023)
    Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
    Cell Rep Methods, 3 (12), 100654
    DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
  3. Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
    Standardized assays to monitor drug sensitivity in hematologic cancers
    Cell Death Discov, 9 (1), 435
    DOI 10.1038/s41420-023-01722-5, PubMed 38040674
  4. Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T (2023)
    Robust scoring of selective drug responses for patient-tailored therapy selection
    Nat Protoc, 19 (1), 60-82
    DOI 10.1038/s41596-023-00903-x, PubMed 37996540
  5. Hanes R, Ayuda-Durán P, Rønneberg L, Nakken S, Hovig E, Zucknick M, Enserink JM (2023)
    screenwerk: a modular tool for the design and analysis of drug combination screens
    Bioinformatics, 39 (1)
    DOI 10.1093/bioinformatics/btac840, PubMed 36573326
  6. Johannessen JA, Formica M, Haukeland ALC, Bråthen NR, Al Outa A, Aarsund M, Therrien M, Enserink JM, Knævelsrud H (2023)
    The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae
    iScience, 26 (10), 107726
    DOI 10.1016/j.isci.2023.107726, PubMed 37720104
  7. Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
    Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Cell Rep Methods, 3 (3), 100417
    DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
  8. Ramos-Alonso L, Holland P, Le Gras S, Zhao X, Jost B, Bjørås M, Barral Y, Enserink JM, Chymkowitch P (2023)
    Mitotic chromosome condensation resets chromatin to safeguard transcriptional homeostasis during interphase
    Proc Natl Acad Sci U S A, 120 (4), e2210593120
    DOI 10.1073/pnas.2210593120, PubMed 36656860
  9. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 115
    DOI 10.1038/s41467-022-35624-4, PubMed 36611026
  10. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 1767
    DOI 10.1038/s41467-023-37488-8, PubMed 36997540
  11. Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K (2023)
    Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data
    ArXiv
    PubMed 37396610

Publications 2022

  1. Enserink JM (2022)
    The SUMO stress response in transcriptional regulation: Causal relationships or secondary bystander effects?
    Bioessays, 44 (7), e2200065
    DOI 10.1002/bies.202200065, PubMed 35655365
  2. Enserink JM, Chymkowitch P (2022)
    Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries
    Int J Mol Sci, 23 (3)
    DOI 10.3390/ijms23031293, PubMed 35163213
  3. Ramos-Alonso L, Garcia I, Enserink JM, Chymkowitch P (2022)
    Analysis of the pheromone signaling pathway by RT-qPCR in the budding yeast Saccharomyces cerevisiae
    STAR Protoc, 3 (1), 101210
    DOI 10.1016/j.xpro.2022.101210, PubMed 35265859
  4. Zhao X, Hendriks IA, Le Gras S, Ye T, Ramos-Alonso L, Nguéa P A, Lien GF, Ghasemi F, Klungland A, Jost B, Enserink JM, Nielsen ML, Chymkowitch P (2022)
    Waves of sumoylation support transcription dynamics during adipocyte differentiation
    Nucleic Acids Res, 50 (3), 1351-1369
    DOI 10.1093/nar/gkac027, PubMed 35100417

Publications 2021

  1. Caulier B, Enserink JM, Wälchli S (2021)
    Pharmacologic Control of CAR T Cells
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094320, PubMed 33919245
  2. Garcia I, Orellana-Muñoz S, Ramos-Alonso L, Andersen AN, Zimmermann C, Eriksson J, Bøe SO, Kaferle P, Papamichos-Chronakis M, Chymkowitch P, Enserink JM (2021)
    Kel1 is a phosphorylation-regulated noise suppressor of the pheromone signaling pathway
    Cell Rep, 37 (13), 110186
    DOI 10.1016/j.celrep.2021.110186, PubMed 34965431
  3. Grad I, Hanes R, Ayuda-Durán P, Kuijjer ML, Enserink JM, Meza-Zepeda LA, Myklebost O (2021)
    Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
    PLoS One, 16 (3), e0248140
    DOI 10.1371/journal.pone.0248140, PubMed 33690666
  4. Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM et al. (2021)
    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
    Autophagy, 17 (1), 1-382
    DOI 10.1080/15548627.2020.1797280, PubMed 33634751
  5. Melvold K, Giliberto M, Karlsen L, Ayuda-Durán P, Hanes R, Holien T, Enserink J, Brown JR, Tjønnfjord GE, Taskén K, Skånland SS (2021)
    Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Mol Oncol, 16 (5), 1153-1170
    DOI 10.1002/1878-0261.13153, PubMed 34861096
  6. Rønneberg L, Cremaschi A, Hanes R, Enserink JM, Zucknick M (2021)
    bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments
    Brief Bioinform, 22 (6)
    DOI 10.1093/bib/bbab251, PubMed 34308471

Publications 2020

  1. Omsland M, Andresen V, Gullaksen SE, Ayuda-Durán P, Popa M, Hovland R, Brendehaug A, Enserink J, McCormack E, Gjertsen BT (2020)
    Tyrosine kinase inhibitors and interferon-α increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines
    FASEB J, 34 (3), 3773-3791
    DOI 10.1096/fj.201802061RR, PubMed 31945226
  2. Tadele DS, Robertson J, Crispin R, Herrera MC, Chlubnová M, Piechaczyk L, Ayuda-Durán P, Singh SK, Gedde-Dahl T, Fløisand Y, Skavland J, Wesche J, Gjertsen BT, Enserink JM (2020)
    A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
    J Biol Chem, 296, 100179
    DOI 10.1074/jbc.RA120.015285, PubMed 33303632

Publications 2019

  1. Nguéa P A, Robertson J, Herrera MC, Chymkowitch P, Enserink JM (2019)
    Desumoylation of RNA polymerase III lies at the core of the Sumo stress response in yeast
    J Biol Chem, 294 (49), 18784-18795
    DOI 10.1074/jbc.RA119.009721, PubMed 31676685
  2. Prikrylova T, Robertson J, Ferrucci F, Konorska D, Aanes H, Manaf A, Zhang B, Vågbø CB, Kuśnierczyk A, Gilljam KM, Løvkvam-Køster C, Otterlei M, Dahl JA, Enserink J, Klungland A, Robertson AB (2019)
    5-hydroxymethylcytosine Marks Mammalian Origins Acting as a Barrier to Replication
    Sci Rep, 9 (1), 11065
    DOI 10.1038/s41598-019-47528-3, PubMed 31363131
  3. Zhang B, Ayuda-Durán P, Piechaczyk L, Fløisand Y, Safont MM, Karlsen IT, Fandalyuk Z, Tadele D, van Mierlo P, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM (2019)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, 104 (5), e229
    DOI 10.3324/haematol.2019.220533, PubMed 31040234

Publications 2018

  1. Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
    Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
    Nucleic Acids Res, 46 (22), 11698-11711
    DOI 10.1093/nar/gky846, PubMed 30247619
  2. Herrera MC, Chymkowitch P, Robertson JM, Eriksson J, Bøe SO, Alseth I, Enserink JM (2018)
    Corrigendum: Cdk1 gates cell cycle-dependent tRNA synthesis by regulating RNA polymerase III activity
    Nucleic Acids Res, 46 (22), 12188-12189
    DOI 10.1093/nar/gky1102, PubMed 30395271
  3. Kruitwagen T, Chymkowitch P, Denoth-Lippuner A, Enserink J, Barral Y (2018)
    Centromeres License the Mitotic Condensation of Yeast Chromosome Arms
    Cell, 175 (3), 780-795.e15
    DOI 10.1016/j.cell.2018.09.012, PubMed 30318142
  4. Zhang B, Durán PA, Piechaczyk L, Fløisand Y, Safont MMS, Karlsen IT, Fandalyuk Z, Tadele D, Mierlo PV, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM, Bjørn Tore Gjertsen Group, Emmet McCormack Group (2018)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, Online ahead of print (in press) (Retracted)
    DOI 10.3324/haematol.2018.189399, PubMed 29748445

Publications 2017

  1. Chymkowitch P, Enserink JM (2017)
    Regulation of tRNA synthesis by posttranslational modifications of RNA polymerase III subunits
    Biochim Biophys Acta Gene Regul Mech, 1861 (4), 310-319
    DOI 10.1016/j.bbagrm.2017.11.001, PubMed 29127063
  2. Chymkowitch P, Nguéa P A, Aanes H, Robertson J, Klungland A, Enserink JM (2017)
    TORC1-dependent sumoylation of Rpc82 promotes RNA polymerase III assembly and activity
    Proc Natl Acad Sci U S A, 114 (5), 1039-1044
    DOI 10.1073/pnas.1615093114, PubMed 28096404
  3. Chymkowitch P, P AN, Aanes H, Koehler CJ, Thiede B, Lorenz S, Meza-Zepeda LA, Klungland A, Enserink JM (2017)
    Corrigendum: Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes
    Genome Res, 27 (2), 334
    DOI 10.1101/gr.218370.116, PubMed 28148563
  4. Enserink J, Nguéa P A, Chymkowitch P (2017)
    Anabolic transcription: Secrets of the sumo diet
    Cell Cycle, 16 (7), 593-594
    DOI 10.1080/15384101.2017.1294945, PubMed 28278057
  5. Enserink JM (2017)
    Regulation of Cellular Processes by SUMO: Understudied Topics
    Adv Exp Med Biol, 963, 89-97
    DOI 10.1007/978-3-319-50044-7_5, PubMed 28197907
  6. Enserink JM (2017)
    Sumo during stress: When transcription takes a pause (comment on DOI.10.1002/bies.201600263)
    Bioessays, 39 (6)
    DOI 10.1002/bies.201700065, PubMed 28464310
  7. Pietarinen PO, Eide CA, Ayuda-Durán P, Potdar S, Kuusanmäki H, Andersson EI, Mpindi JP, Pemovska T, Kontro M, Heckman CA, Kallioniemi O, Wennerberg K, Hjorth-Hansen H, Druker BJ, Enserink JM, Tyner JW, Mustjoki S, Porkka K (2017)
    Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
    Oncotarget, 8 (14), 22606-22615
    DOI 10.18632/oncotarget.15146, PubMed 28186983
  8. Zimmermann C, Garcia I, Omerzu M, Chymkowitch P, Zhang B, Enserink JM (2017)
    Mapping the Synthetic Dosage Lethality Network of CDK1/CDC28
    G3 (Bethesda), 7 (6), 1753-1766
    DOI 10.1534/g3.117.042317, PubMed 28428242
  9. Zimmermann C, Santos A, Gable K, Epstein S, Gururaj C, Chymkowitch P, Pultz D, Rødkær SV, Clay L, Bjørås M, Barral Y, Chang A, Færgeman NJ, Dunn TM, Riezman H, Enserink JM (2017)
    TORC1 Inhibits GSK3-Mediated Elo2 Phosphorylation to Regulate Very Long Chain Fatty Acid Synthesis and Autophagy
    Cell Rep, 18 (8), 2073-2074
    DOI 10.1016/j.celrep.2017.02.020, PubMed 28228270

Publications 2016

  1. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM et al. (2016)
    Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
    Autophagy, 12 (1), 1-222
    DOI 10.1080/15548627.2015.1100356, PubMed 26799652

Publications 2015

  1. Chymkowitch P, Nguéa P A, Enserink JM (2015)
    SUMO-regulated transcription: challenging the dogma
    Bioessays, 37 (10), 1095-105
    DOI 10.1002/bies.201500065, PubMed 26354225
  2. Chymkowitch P, Nguéa AP, Aanes H, Koehler CJ, Thiede B, Lorenz S, Meza-Zepeda LA, Klungland A, Enserink JM (2015)
    Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes
    Genome Res, 25 (6), 897-906
    DOI 10.1101/gr.185793.114, PubMed 25800674
  3. Enserink JM (2015)
    Sumo and the cellular stress response
    Cell Div, 10, 4
    DOI 10.1186/s13008-015-0010-1, PubMed 26101541

Publications 2014

  1. Davydova E, Ho AYY, Malecki J, Moen A, Enserink JM, Jakobsson ME, Loenarz C, Falnes PØ (2014)
    Identification and characterization of a novel evolutionarily conserved lysine-specific methyltransferase targeting eukaryotic translation elongation factor 2 (eEF2)
    J Biol Chem, 289 (44), 30499-30510
    DOI 10.1074/jbc.M114.601658, PubMed 25231979
  2. Enserink JM (2014)
    Metabolic pathways further increase the complexity of cell size control in budding yeast
    Microb Cell, 1 (9), 276-278
    DOI 10.15698/mic2014.09.167, PubMed 28362005

Publications 2013

  1. Zimmermann C, Santos A, Gable K, Epstein S, Gururaj C, Chymkowitch P, Pultz D, Rødkær SV, Clay L, Bjørås M, Barral Y, Chang A, Færgeman NJ, Dunn TM, Riezman H, Enserink JM (2013)
    TORC1 inhibits GSK3-mediated Elo2 phosphorylation to regulate very long chain fatty acid synthesis and autophagy
    Cell Rep, 5 (4), 1036-46
    DOI 10.1016/j.celrep.2013.10.024, PubMed 24239358

Publications 2012

  1. Chymkowitch P, Eldholm V, Lorenz S, Zimmermann C, Lindvall JM, Bjørås M, Meza-Zepeda LA, Enserink JM (2012)
    Cdc28 kinase activity regulates the basal transcription machinery at a subset of genes
    Proc Natl Acad Sci U S A, 109 (26), 10450-5
    DOI 10.1073/pnas.1200067109, PubMed 22689984
  2. Chymkowitch P, Enserink JM (2012)
    The cell cycle rallies the transcription cycle: Cdc28/Cdk1 is a cell cycle-regulated transcriptional CDK
    Transcription, 4 (1), 3-6
    DOI 10.4161/trns.22456, PubMed 23131667
  3. Enserink JM (2012)
    Chemical genetics: budding yeast as a platform for drug discovery and mapping of genetic pathways
    Molecules, 17 (8), 9258-73
    DOI 10.3390/molecules17089258, PubMed 22858845
  4. Enserink JM, Kolodner RD (2012)
    What makes the engine hum: Rad6, a cell cycle supercharger
    Cell Cycle, 11 (2), 249-52
    DOI 10.4161/cc.11.2.19023, PubMed 22214660
  5. Pultz D, Bennetzen MV, Rødkær SV, Zimmermann C, Enserink JM, Andersen JS, Færgeman NJ (2012)
    Global mapping of protein phosphorylation events identifies Ste20, Sch9 and the cell-cycle regulatory kinases Cdc28/Pho85 as mediators of fatty acid starvation responses in Saccharomyces cerevisiae
    Mol Biosyst, 8 (3), 796-803
    DOI 10.1039/c2mb05356j, PubMed 22218487

Publications 2011

  1. Zimmermann C, Chymkowitch P, Eldholm V, Putnam CD, Lindvall JM, Omerzu M, Bjørås M, Kolodner RD, Enserink JM (2011)
    A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6-Bre1 to cell cycle progression
    Proc Natl Acad Sci U S A, 108 (46), 18748-53
    DOI 10.1073/pnas.1115885108, PubMed 22042866

Publications 2010

  1. Enserink JM, Kolodner RD (2010)
    An overview of Cdk1-controlled targets and processes
    Cell Div, 5, 11
    DOI 10.1186/1747-1028-5-11, PubMed 20465793

Publications 2009

  1. Enserink JM, Hombauer H, Huang ME, Kolodner RD (2009)
    Cdc28/Cdk1 positively and negatively affects genome stability in S. cerevisiae
    J Cell Biol, 185 (3), 423-37
    DOI 10.1083/jcb.200811083, PubMed 19398760
  2. Kats ES, Enserink JM, Martinez S, Kolodner RD (2009)
    The Saccharomyces cerevisiae Rad6 postreplication repair and Siz1/Srs2 homologous recombination-inhibiting pathways process DNA damage that arises in asf1 mutants
    Mol Cell Biol, 29 (19), 5226-37
    DOI 10.1128/MCB.00894-09, PubMed 19635810

Publications 2006

  1. Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, Taskén K (2006)
    The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages
    J Immunol, 176 (12), 7361-70
    DOI 10.4049/jimmunol.176.12.7361, PubMed 16751380
  2. Enserink JM, Smolka MB, Zhou H, Kolodner RD (2006)
    Checkpoint proteins control morphogenetic events during DNA replication stress in Saccharomyces cerevisiae
    J Cell Biol, 175 (5), 729-41
    DOI 10.1083/jcb.200605080, PubMed 17130284
  3. Smolka MB, Chen SH, Maddox PS, Enserink JM, Albuquerque CP, Wei XX, Desai A, Kolodner RD, Zhou H (2006)
    An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth
    J Cell Biol, 175 (5), 743-53
    DOI 10.1083/jcb.200605081, PubMed 17130285

Publications 2004

  1. Enserink JM, Price LS, Methi T, Mahic M, Sonnenberg A, Bos JL, Taskén K (2004)
    The cAMP-Epac-Rap1 pathway regulates cell spreading and cell adhesion to laminin-5 through the alpha3beta1 integrin but not the alpha6beta4 integrin
    J Biol Chem, 279 (43), 44889-96
    DOI 10.1074/jbc.M404599200, PubMed 15302884
  2. Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
    The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
    Endocrinology, 145 (11), 5177-84
    DOI 10.1210/en.2004-0232, PubMed 15284208
  3. Vang T, Abrahamsen H, Myklebust S, Enserink J, Prydz H, Mustelin T, Amarzguioui M, Tasken K (2004)
    Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells
    Eur J Immunol, 34 (8), 2191-9
    DOI 10.1002/eji.200425036, PubMed 15259016

Publications 2003

  1. Bos JL, de Bruyn K, Enserink J, Kuiperij B, Rangarajan S, Rehmann H, Riedl J, de Rooij J, van Mansfeld F, Zwartkruis F (2003)
    The role of Rap1 in integrin-mediated cell adhesion
    Biochem Soc Trans, 31 (Pt 1), 83-6
    DOI 10.1042/bst0310083, PubMed 12546659
  2. Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL (2003)
    Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor
    J Cell Biol, 160 (4), 487-93
    DOI 10.1083/jcb.200209105, PubMed 12578910

Publications 2002

  1. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Døskeland SO, Blank JL, Bos JL (2002)
    A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK
    Nat Cell Biol, 4 (11), 901-6
    DOI 10.1038/ncb874, PubMed 12402047
  2. Verschure PJ, Van Der Kraan I, Enserink JM, Moné MJ, Manders EM, Van Driel R (2002)
    Large-scale chromatin organization and the localization of proteins involved in gene expression in human cells
    J Histochem Cytochem, 50 (10), 1303-12
    DOI 10.1177/002215540205001003, PubMed 12364563

Publications 2000

  1. Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ (2000)
    Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2
    J Cell Physiol, 185 (2), 269-79
    DOI 10.1002/1097-4652(200011)185:2<269::AID-JCP12>3.0.CO;2-L, PubMed 11025449
 
Scroll to top